Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Substance from human umbilical cord blood cells promotes hair growth.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The SAFE System for hair transplants results in low damage to follicles and could make the procedure suitable for more patients.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Scientists made a mouse that shows how a specific protein in the skin changes and affects hair growth and shape.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Lower irisin levels in the blood may indicate more severe acne.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The endobrow-midface lift is a safe and effective way to rejuvenate the upper face with minimal complications and rare temporary hair loss.